Insilico, A2A launch Consortium.AI to develop candidates for rare orphan diseases

Insilico Medicine Inc. (Baltimore, Md.) and A2A Pharmaceuticals LLC (Chappaqua, N.Y.) partnered to launch Consortium.AI,

Read the full 157 word article

User Sign In